Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Clinical trial NCT06822426 · RECRUITING

Trial details

NCT number: NCT06822426
Sponsor: CorMedix Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Central Line Associated Blood Stream Infections (CLABSI)

Start date: 2025-05-14
Primary completion: 2028-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.